Vascular Endothelial Growth Factor and microvascular permeability

Microcirculation

Volumn 6, Issue 2, 1999, Pages 83-96

  Bates, David O ^a   Lodwick, David ^b   Williams, Bryan ^b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b NONE

Author keywords

Angiogenesis; Microvascular permeability; Vascular endothelial growth factors; Vasodilatation

Indexed keywords

ENDOTHELIAL CELL GROWTH FACTOR; LYMPHOKINE; VASCULOTROPIN; VASCULOTROPIN A;

ANIMAL; CAPILLARY PERMEABILITY; DRUG EFFECT; HEMODYNAMICS; HUMAN; MICROCIRCULATION; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; VASODILATATION;

ANIMALS; CAPILLARY PERMEABILITY; ENDOTHELIAL GROWTH FACTORS; HEMODYNAMIC PROCESSES; HUMANS; LYMPHOKINES; MICROCIRCULATION; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; VASODILATION;

EID: 0033146795     PISSN: 10739688     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1549-8719.1999.tb00091.x     Document Type: Review

References (116)

1. Abedi H, Zachary I. (1997). Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells. J Biol Chem 272:15442-15451.
2. Achen MG, Jeltsch M, Kukk E, Makinen T, Vitali A, Wilks AF, Alitalo K, Stacker SA. (1998). Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci USA 95:548-53.
3. Adamis AP, Shima DT, Tolentino MJ, Gragoudas ES Ferrara N Folkman J, D'Amore PA, Miller JW. (1996).Inhibition of vascular endothelial growth factor prevents retinal ischemia-Associated iris neovascularization in a nonhuman primate. Arch Ophthalmol 114:66-71.
4. Aiello LP, Bursell SE, Clermont A, Duh E, Ishii H, Takagi, C, Mori, F, Ciulla TA, Ways K, Jirousek M, Smith LE, King GL (1997)Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor. Diabetes 46:1473-1480.
5. Bates DO. (1998).The chronic effect of vascular endothelial growth factor (VEGF) on individually perfused frog mesenteric microvessels. J Physiol 513: 225-233.
6. Bates DO. (1998). Chronically increased hydraulic conductivity (Lp) by vascular endothelial growth factor (VEGF) is attenuated by inhibition of nitric oxide synthase. J Vasc Res (in press).
7. Bates DO. (1998).Vascular endothelial growth factor (VEGF) chronically increases microvascular hydraulic conductivity (Lp) without affecting oncotic reflection coefficient (s). FASEB J 12:A22 (Abstr).
8. Bates DO, Curry FE. (1996).Vascular endothelial growth factor increases hydraulic conductivity of isolated perfused microvessels. Am J Physiol Heart Circul Physiol 271:H2520-H2528.
9. Bates DO, Curry FE. (1997).Vascular endothelial growth factor increases microvascular permeability via a Ca(2+)-dependent pathway. Am J Physiol Heart Circul Physiol 273: H687-H694.
10. Baumgartner I, Pieczek A, Manor O, Blair R, Kearney M, Walsh K, Isner JM. (1998). Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 97: 1114-1123.
11. Berridge MJ. (1993). Inositol trisphosphate and calcium signalling. Nature 361:315-325
12. Brock TA, Dvorak HF, Senger DR. (1991).Tumor-secreted vascular permeability factor increases cytosolic Ca2+ and von Willebrand factor release in human endothelial cells. Am J Pathol 138:213-221.
13. Brown LF, Berse B, Jackman RW, Tognazzi K, Guidi AJ, Dvorak HF, Senger DR, Connolly JL, Schnitt SJ. (1995). Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol 26:86-91.
14. Brown LF, Harrist TJ, Yeo KT, Stahle-Backdahl M, Jackman RW, Berse B, Tognazzi K, Dvorak HF, Detmar M. (1995). Increased expression of vascular permeability factor (vascular endothelial growth factor) in bullous pemphigoid dermatitis herpetiformis and erythema multiforme. J Invest Dermatol 104:744-749.
15. Brown LF, Yeo KT, Berse B, Yeo TK, Senger DR, Dvorak HF, van de Water L. (1992). Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 176:1375-1379.
16. Brown MA, Wang MX, Buddle ML, Carlton MA, Cario GM, Zammit VC, Whitworth JA. (1994). Albumin excretory rate in normal and hypertensive pregnancy. Clin Sci 86:251-255.
17. Bull RH, Bates DO, Mortimer PS. (1992). Intravital video-capillaroscopy for the study of the microcirculation in psoriasis. Brit J Dermatol 126:436-445.
18. Chuang PT, Cheng HJ, Lin SJ, Jan KM, Lee MM, Chien S. (1990). Macroinolecular transport across arterial and venous endothelium in rats. Studies with Evans blue-albumin and horseradish peroxidase. Arteriosclerosis 10:188-197.
19. Collins PD, Connolly DT, Williams TJ. (1993). Characterization of the increase in vascular permeability induced by vascular permeability factor in vivo. Br J Pharm 109:195-199.
20. Connolly DT, Heuvelinan DM, Nelson R, Olander JV, Eppley BL, Delfino JJ, Siegel NR, Leimgruber RM, Feder J. (1989).Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis J Clin Inv 84:1470-1478.
21. Criscuolo GR, Lelkes PI, Rotrosen D, Oldfield EH. (1989). Cytosolic calcium changes in endothelial cells induced by a protein product of human gliomas containing vascular permeability factor activity. J Neurosurg 71:884-891.
22. Criscuolo GR, Merrill MJ, Oldfield EHJN. (1988). Further characterization of malignant gliomaderived vascular permeability factor. J Neurosurg 69:254-262.
23. Cullinan-Bove K, Koos RD. (1993). Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth. Endocrinol 133:829-837.
24. Curry FE. (1984). Mechanics and thermodynamics of transcapillary exchange. In: Handbook of Physiology. The Cardiovascular System. Microcirculation, 2nd edition (CC Michel and EM Renkin, Eds.). Bethesda. American Physiological Society. 309-373.
25. de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT. (1992). The fms-like tyrosine kinase a receptor for vascular endothelial growth factor. Science 255:989-991.
26. Detmar M, Brown LF, Claffey KP, Yeo KT, Kocher O, Jackman RW, Berse B, Dvorak UF. (1994). Over-expression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med 180:1141-1146.
27. DiSalvo J, Bayne ML, Conn G, Kwok PW, Trivedi PG, Soderman DD, Palisi TM, Sullivan KA, Thomas KA. (1995). Purification and characterization of a naturally occurring vascular endothelial growth factor/placenta growth factor heterodimer. J Biol Chem 270:7717-7723.
28. Dvorak HF, Brown LF, Detmar M, Dvorak AM. (1995). Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability and angiogenesis. Am J Pathol 146:1029-1039.
29. Fagrell B. (1984). Microcirculation of the skin. In: The Physiology and Pharmacology of the Microcirculation (Mortillaro NA, Ed.). Orlando, FL. Academic Press. 133-180.
30. Fava RA, Olsen NJ, Spencer-Green G, Yeo KT, Yeo TK, Berse B, Jackman RW, Senger DR, Dvorak HF, Brown LF. (1994). Vascular permeability factor/endothelial growth factor (VPF/VEGF): Accumulation and expression in human synovial fluids and rheumatoid synovial tissue J Exp Med 180:341-346.
31. Favard C, Moukadiri II, Dorey C, Praloran V, Plouet J. (1991). Purification and biological properties of vasculotropin a new angiogenic cytokine. Biol Cell 73:1-6.
32. Feng D, Nagy JA, Hipp J, Pyne K, Dvorak HF, Dvorak AM. (1997). Reinterpretation of endothelial cell gaps induced by vasoactive mediators in guinea pig mouse and rat: Many are transcellular pores. J Physiol 504:747-761.
33. Ferrara N, Bunting S. (1996). Vascular endothelial growth factor, a specific regulator of angiogenesis. Curr Opin Nephrol Hypertens 5:35-44.
34. Ferrara N , Henzel WJ. (1989). Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Comm 161:851-858.
35. Ferrara N, Houck KA, Jakeman LB, Winer J, Leung DW. (1991). The vascular endothelial growth factor family of polypeptides. J Cell Biochem 47:211-218.
36. Finnerty H, Kelleher K, Morris GE, Bean K, Merberg DM, Kriz R, Morris JC, Sookdeo H, Turner KJ, Wood CR. (1993). Molecular cloning of murine FLT and FLT4. Oncogene 8:2293-2298.
37. Folkman J, Shing Y. (1992). Angiogenesis. J Biol Chem 267:10931-10934.
38. Guo D, Jia Q, Song HY, Warren RS, Donner DB. (1995). Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation. J Biol Chem 270:6729-6733.
39. Hariawala MD, Horowitz JJ, Esakof D, Sheriff DD, Walter DII, Keyt B, Isner JM, Symes JF. (1996). VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts. J Surg Res 63: 77-82.
40. 2+] and microvessel permeability. Am J Physiol Heart Circul Physiol 272:H176-H185.
41. Hood J, Granger HJ. (1998). Protein Kinase G mediates VEGF-induced raf-1 activation and proliferation in human endothelial cells. J Biol Chem 273:23504-23508.
42. Horowitz JR, Rivard A, van der Zee R, Hariawala M, Sheriff DD, Esakof DD, Chaudhry GM, Symes JF, Isner JM. (1997)Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotension. Evidence for a maintenance role in quiescent adult endothelium. Arterioscler Thromb Vasc Biol 17:2793-2800.
43. Isner JM, Walsh K, Symes J, Pieczek A, Takeshita S, Lowry J, Rossow S, Rosenfield K, Weir L, Brogi E et al. (1995). Arterial gene therapy for therapeutic angiogenesis in patients with peripheral artery disease. Circulation 91:2687-2692.
44. Iwasaka C, Tanaka K, Abe M, Sato Y. (1996). Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells. J Cell Physiol 169:522-531.
45. Joukov V, Kaipainen A, Jeltsch M, Pajusola K, Olofsson B, Kumar V, Eriksson U, Alitalo K. (1997). Vascular endothelial growth factors VEGF-B and VEGF-C. J Cell Physiol 173:211-215.
46. Joukov V, Kumar V, Sorsa T, Arighi E, Weich II, Saksela O, Alitalo K. (1998). A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding activation and vascular permeability activities. J Biol Chem 273:6599-6602.
47. Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo K. (1996). A novel vascular endothelial growth factor VEGF-C is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. Embo J 15:290-298.
48. Kaipainen A, Korhonen J, Pajusola K, Aprelikova O, Persico MG, Terman BI, Alitalo K. (1993). The related FLT4 FLT1 and KDR receptor tyrosinc kinases show distinct expression patterns in human fetal endothelial cells. J Exp Med 178:2077-2088.
49. Keck PJ, Hauser S D, Krivi G, Sanzo K, Warren T, Feder J, Connolly DT. (1989). Vascular permeability factor an endothelial cell mitogen related to PDGF. Science 246:1309-1312.
50. Kendall RL, Thomas KA. (1993). Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci USA 90:10705-10709.
51. Kendall RL, Wang G, Thomas KA. (1996). Identification of a natural soluble form of the vascular endothelial growth factor receptor FLT-1 and its heterodimerization with KDR. Biochem Biophys Res Comm 226:324-328.
52. Kevil CG, Payne D K, Mire E, Alexander JS. (1998). Vascular permeability factor/vascular endothelial cell growth factor-mediated permeability occurs through disorganization of endothelial junctional proteins. J Biol Chem 273:15099-15103
53. Kitamoto Y, Tokunaga H, Tomita K. (1997) Vascular endothelial growth factor is an essential molecule for mouse kidney development: Glomerulogenesis and nephrogenesis. J Clin Investig 99:2351-2357.
54. Klanke B, Simon M, Rockl W, Weich HA, H, Grone HJ. (1998). Effects of vascular endothelial growth factor (VEGF)/vascular permeability factor (VPF) on haemodynamics and permselectivity of the isolated perfused rat kidney. Nephrol Dials Transpl 13:875-885.
55. Kolm S, Nagy JA, Dvorak HF, Dvorak AM. (1992). Pathways of macromolecular tracer transport across venules and small veins. Structural basis for the hyperpermeability of tumor blood vessels. Lab Invest 67:596-607.
56. Kroll J, Waltenberger J. (1997). The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells. J Biol Chem 272:32521-32527.
57. Ku DD, Zaleski JK, Liu S, Brock TA. (1993). Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am J Physiol Heart Circul Physiol 265:H586-H592.
58. Lee J, Gray A, Yuan J, Luoh SM, Avraham H, Wood WI. (1996). Vascular endothelial growth factor-related protein: A ligand and specific activator of the tyrosine kinase receptor Flt4. Proc Natl Acad Sci USA 93:1988-1992.
59. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. (1989). Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306-1309.
60. Lev S, Moreno H, Martinez R, Canoll P, Peles E, Musacchio JM, Plowman GD, Rudy B, Schlessinger J.-(1995) Protein tyrosine kinase PYK2 involved in Ca(2+)-induced regulation of ion channel and MAP kinase functions. Nature 376:737-745.
61. Levick JR. (1991). An Introduction to Cardiovascular Physiology. Butterworths. London.
62. Levy AP, Levy NS, Loscalzo J, Calderone A, Takahashi N, Yeo KT, Koren G, Colucci WS, Goldberg MA. (1995). Regulation of vascular endothelial growth factor in cardiac myocytes. Cire Res 76:758-766.
63. Lin SJ, Hong CY, Chang MS, Chiang BN, Chien S. (1993). Increased aortic endothelial death and enhanced transendothelial macromolecular transport in streptozotocin-diabetic rats. Diabetologia 36: 926-930.
64. Lin SJ, Jan KM, Schuessler G, Weinbaum S, Chien S. (1988). Enhanced macromolecular permeability of aortic endothelial cells in association with mitosis. Atherosclerosis 73:223-232.
65. Maglione D, Guerriero V, Viglietto G, Delli-Bovi P, Persico MG. (1991).Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA 88: 9267-9271.
66. Malavaud B, Tack I. Jonca F, Praddaude F, Moro F, Ader JL, Plouet J. (1997). Activation of Flk-1/KDR mediates angiogenesis but not hypotension. Cardiovasc Res 36:276-281.
67. Michel CC. (1980). Filtration coefficients and osmotic reflexion coefficients of the walls of single frog mesenteric capillaries. J Physiol 309:341-355.
68. Michel CC. (1984). Fluid movements through capillary walls. In: Handbook of Physiology. The Cardiovascular system. Microcirculation, 2nd edition (CC Michel and EM Renkin, Eds.) American Physiological Society. Bethesda, MD. 375-409.
69. Michel CC. (1997). Starling: The formulation of his hypothesis of microvascular fluid exchange and its significance after 100 years. Exp Physiol 82:1-30.
70. Michel CC. (1996). Transport of macromolecules through microvascular walls. Cardiovasc Res 32: 644-653.
71. Michel CC, Mason JC, Curry FE, Tooke JE, Hunter PJ. (1974). A development of the Landis technique for measuring the filtration coefficient of individual capillaries in the frog mesentery. Qrt J Exp Physiol Cogn Med Sci 59:283-309.
72. Michel CC, Phillips ME. (1987). Steady-state fluid filtration at different capillary pressures in perfused frog mesenteric capillaries. J Physiol 388:421-435.
73. Miles A, Miles E. (1952). Vascular reactions to histamine histamine-liberator and leukotaxine in the skin of guinea pigs. J Physiol 118:228-257.
74. Mukhopadhyay D, Nagy JA, Manseau EJ, Dvorak HF. (1998). Vascular permeability factor/vascular endothelial growth factor-mediated signaling in mouse mesentery vascular endothelium. Canc Res 58:1278-1284.
75. Natarajan R, Bai W, Lanting L, Gonzales N. Nadler J. (1997). Effects of high glucose on vascular endothelial growth factor expression in vascular smooth muscle cells. Am J Physiol 273:H2224-H2231.
76. Neal CR, Michel CC. (1998). Differing effects of vascular endothelial growth factor (VECF) on the ultrastructure of microvascular endothelium of mesenteric microvessels of frog and rat. J Physiol 506P:24P-25P.
77. Neal CR, Michel CC. (1997)Vascular endothelial growth factor (VEGF) increases permeability by inducing openings through endothelial cells. Intl J Microcirc: Clin Exp 17:198(Abstr).
78. Olofsson B, Korpelainen E, Mandriota S, Pepper MS, Aase K, Kumar V, Gunji Y, Jeltsch MM, Shibuya M, Alitalo K, Eriksson U. (1998).VEGF-B binds to VEGFR-1 and regulates plasminogen activator activity in endothelial cells. Proc Natl Acad Sci USA (in press).
79. Olofsson B, Pajusola K,Kaipainen A, Von Euler G, Joukov V, Saksela O, Orpana A, Pettersson RF, Alitalo K, Eriksson U. (1996). Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci USA 93:2576-2581.
80. Ogawa S, Oku A, Sawano A, Yamaguchi S, Yazaki Y. Shibuya M. (1998). A novel type of vascular endothelial growth factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain. J Biol Chem 273:31273-31282.
81. Orlandini M, Marconcini L, Ferruzzi R, Oliviero S. (1996). Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family. Proc Natl Acad Sci USA 93:11675-11680.
82. Pajusola K, Aprelikova O, Korhonen J, Kaipainen A, Pertovaara L, Alitalo R, Alitalo K. (1992). FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines. Canc Res 52:5738-5743.
83. Pappenheimer JR, Soto-Rivera A. (1948). Effective osmotic pressure of the plasma proteins and other quantities associated with the capillary circulation in the hindlimbs of cats and dogs. Am J Physiol 152: 471-491.
84. Park JE, Chen HH, Winer J, Houck KA, Ferrara N. (1994). Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity in vitro and in vivo and high affinity binding to Fit-1 but not to Flk-1/KDR. J Biol Chem 269:25646-25654.
85. Quinn TP, Peters KG, De Vries C, Ferrara N, Williams LT. (1993). Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium Proc Natl Acad Sci USA 90:7533-7537.
86. Renkin EM. (1986). Some consequences of capillary permeability to macromolecules: Starling's hypothesis reconsidered. Am J Physiol 250:11706-11710.
87. Rippe B, Haraldsson B. (1994).Transport of inacromolecules across microvascular walls: the two-pore theory. Physiol Rev 74:163-219.
88. Risau W. (1997). Mechanisms of angiogenesis. Nature 386:671-674.
89. Roberts WG, Palade GE. (1995). Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 108:2369-2379.
90. Roberts. WG, Palade GE. (1997). Neovasculature induced by vascular endothelial growth factor is fenestrated. Canc Res 57:765-772.
91. Ross R. (1993). The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 362:801-809.
92. Sawano A, Takahashi T, Yamaguchi S, Shibuya M. (1997). The phosphorylated 1169-tyrosine containing region of flt-1 kinase (VEGFR-1) is a major binding site for PLCgamma. Biochem Biophys Res Comm 238:487-491.
93. Senger DR, Connolly DT, Van de Water L, Feder J, Dvorak HF. (1990). Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor. Canc Res 50:1774-1778.
94. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. (1983). Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219:983-985.
95. Senger DR, Perruzzi CA, Feder J, Dvorak HF. (1986). A highly conserved vascular permeability factor secreted by. a variety of human and rodent tumor cell lines. Canc Res 46:5629-5632.
96. Simon M, Grone HJ, Johren O, Kullmer J, Plate KH, Risau W, Fuchs E. (1995). Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney. Am J Physiol 268:F240-F250.
97. Sirois MG, Edelman ER. (1997).VEGF effect on vascular permeability is mediated by synthesis of platelet-activating factor. Am J Physiol Heart Circul Physiol 272:H2746-H2756.
98. Strawn LM, McMahon G, App H, Schreck R, Kuchler WR, Longhi MP, Hui TH, Tang C, Levitzki A, Gazit A, Chen I, Keri G, Orfi L, Risau W, Flamme I, Ullrich A, Hirth KP, Shawver LK. (1996). Flk-1 as a target for tumor growth inhibition. Canc Res 56:3540-3545.
99. Takahashi T, Shibuya M. (1997). The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mitotic signals in NIH3T3 fibroblasts. Oncogene 14:2079-2089.
100. Taylor AE, Granger DN. (1984). Exchange of macromoleculcs across the microcirculation. In: Handbook of Physiology. The Cardiovascular System. Microcirculation (CC Michel and EM Renkin, Eds.) American Physiological Society. Bethesda, MD. 467-520.
101. Terman BI, Dougher-Vermazen M, Carrion ME, Dimitrov D, Armellino DC, Gospodarowicz D, Bohlen P. (1992). Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Comm 187: 1579-1586.
102. Thieme H, Aiello LP, Takagi H, Ferrara N, King GL. (1995). Comparative analysis of vascular endothelial growth factor receptors on retinal and aortic vascular endothelial cells. Diabetes 44:98-103.
103. Tilton RG, Kawamura T, Chang KC, Ido Y, Bjercke RJ, Stephan CC, Brock TA, Williamson JR. (1997). Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor. J Clin Investig 99: 2192-2202.
104. Tsai JC, Goldman CK, Gillespic GY. (1995).Vascular endothelial growth factor in human glioma cell lines: Induced secretion by EGF PDGF-BB and bFGF. J Neurosurg 82:864-873.
105. Tsurumi Y, Kearney M, Chen D, Silver M, Takeshita S, Yang J, Symes JF, Isner JM. (1997). Treatment of acute limb ischemia by intramuscular injection of vascular endothelial growth factor gene. Circulation 96:II-382-388.
106. Tsurumi Y, Murohara T, Krasinski K, Chen D, Witzenbichler B, Kearney M, Couffinhal T, Isner JM. (1997). Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nature Med 3:879-886.
107. Waltenbeger J, Claesson Welsh L, Siegbahn A, Shibuya M, Heldin CH. (1994). Different signal transduction properties of KDR and Flt1 two receptors for vascular endothelial growth factor. J Biol Chem 269:26988-26995.
108. Wheeler-Jones C, Abu-Ghazaleh R, Cospedal R, Houliston RA, Martin J, Zachary I. (1997). Vascular endothelial growth factor stimulates prostacyclin production and activation of cytosolic phospholipase A2 in endothelial cells via p42/p44 mitogen-activated protein kinase. FEBS Lett 420:28-32.
109. Whittle C, Mathieson P, Harper SJ. (1998). Vascular permeability factor mRNA isoform and receptor expression by isolated single human glomeruli. Proc Brit Renal Assoc March: 38.
110. Williams B. (1998). Angiotensin II VEGF and diabetic retinopathy. Lancet 351:837-838.
111. Williams B. (1997). Factors regulating the expression of vascular permeability/ vascular endothelial growth factor by human vascular tissues. Diabetologia 40:S118-S120.
112. Williams B. (1998). A potential role for angiotensin II induced vascular endothelial growth factor expression in the pathogenesis of diabetic nephropathy. Minutes in Electrolyte Metabolism (in press).
113. Wu HM, Huang Q, Yuan Y, Granger HJ. (1996). VEGF induces NO-dependent hyperpenneability in coronary venules. Am J Physiol Heart Circnl Physiol 271:H2735-H2739.
114. Xia P, Aiello L P, Ishii H, Jiang Z Y, Park D J, Robinson G S, Takagi H, Newsome W P, Jirousek M R, King GL. (1996). Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C its isoforms and endothelial cell growth. J Clin Investig 98:2018-2026.
115. Yamada Y, Nezu J I, Shimane M, Hirata Y. (1997). Molecular cloning of a novel vascular endothelial growth factor VEGF-D. Genomics 42:483-488.
116. Yang R, Bunting S, Ko A, Keyt BA, Modi NB, Zioncheck TF, Ferrara N, Jia H. (1998). Substantially attenuated hemodynamic responses to Escherichia coli-derived vascular endothelial growth factor given by intravenous infusion compared with bolus injection. J Pharm Exp Therap 284:103-110.